<DOC>
	<DOCNO>NCT00300040</DOCNO>
	<brief_summary>The purpose study assess safety feasibility HBOC-201 increase adequate wound heal patient severe peripheral vascular disease undergo low limb amputation . The hypothesis HBOC-201 pas partially occlude lesion peripheral artery low extremity promote wound heal process deliver oxygen oxygen deprive tissue . This reduce incidence low limb wind complication 60 day post-surgery may reduce incidence second amputation .</brief_summary>
	<brief_title>Safety/Feasibility Study HBOC-201 Amputation at/Below Knee From Critical Lower Limb Ischemia</brief_title>
	<detailed_description>This Phase II , single-blinded , prospectively randomize , parallel-group , placebo control study evaluate safety feasibility HBOC-201 administer therapeutically patient peripheral vascular occlusive disorder undergo low limb amputation due critical low limb ischemia . Subjects randomize ( 1:1 ) receive either HBOC-201 colloid control ( HAES-steril® 6 % ) .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<mesh_term>HBOC 201</mesh_term>
	<criteria>Subjects ≥ 18 ≤ 75 year age Scheduled amputation ankle joint , proximal location knee joint Documented severe low extremity peripheral artery occlusive disease confirm clinical symptom critical limb ischemia : Frankly gangrenous tissue merit amputation Angiographic evidence occlusive peripheral artery disease within one month screen Participant legal representative sign inform consent Willingness follow study instruction followup visit No informed consent obtain If medically inappropriate administer 250 mL colloidal solution daily 4 consecutive day Uncontrolled hypertension ( BP &gt; 160/90 mm Hg ) despite 2 antihypertensive med BP &gt; 180/100 mm Hg untreated Severe liver dysfunction define Total Bilirubin &gt; 3 mg/dL twice normal limit serum AST ALT Symptomatic CVD diagnose w/ last 6 month know high grade carotid stenosis Any severe unstable medical condition might interfere w/ evaluation study medication Cardiogenic shock ( cardiac index &lt; 2 L/min/m2 , PCWP &gt; 18 mm Hg ) Amputation knee joint ankle joint Any amputation whereby primary skin closure technically feasible Candidate percutaneous surgical revascularization Cardiac failure define NY class III/IV leave ventricular ejection fraction &lt; 30 % Life expectancy &lt; 60 day Systemic mastocytosis Previously demonstrate beef product allergy Myocardial infarction w/ 30 day Participation another trial w/ last 30 day Woman pregnant breastfeeding Amputation know infection site skin closure Renal dysfunction require dialysis , serum creatinine level 2.5 mg/dL Peripheral vascular occlusion cardio arterial embolus Uncontrolled diabetes blood glucose ≥ 400 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Amputation</keyword>
	<keyword>Lower limb</keyword>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>residual limb</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>re-amputation</keyword>
	<keyword>Lower Limb Ischemia</keyword>
	<keyword>PVD</keyword>
</DOC>